Physician profile
Dare Adewumi
NPI 1265605091
$2,576.43
in general payments reported to CMS, 2019-2025
18 companies · $91.44 in 2025
The $91.44 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $409 · 2021: $281 · 2022: $293 · 2023: $968 · 2024: $370 · 2025: $91.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,429.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $1,850.11 | 2020-2024 | Spine Truss System |
| Medtronic, INC. | $346.69 | 2021-2025 | O-Arm, Mazor X System, Cd Horizon Spinal System |
| Arbor Pharmaceuticals, INC. | $63.40 | 2019-2020 | |
| Djo, LLC | $41.44 | 2023-2025 | Cmf |
| Csl Behring | $40.90 | 2019 | |
| Bioventus LLC | $34.51 | 2023 | Nexus |
| Cerapedics INC. | $32.81 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Boston Scientific Corporation | $22.34 | 2025 | Varithena Administration Pack |
| Sanara Medtech INC. | $20.44 | 2025 | Celleraterx |
| Portola Pharmaceuticals, LLC | $20.15 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.64 | 2023 | Andexxa |
| Depuy Synthes Sales INC. | $17.05 | 2019 | |
| Nuvasive, INC. | $16.40 | 2019 | |
| Si-Bone, INC. | $14.43 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.77 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $11.37 | 2020 | |
| Zimmer Biomet Holdings, INC. | $11.32 | 2019 | |
| Ambu INC. | $3.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dare Adewumi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.